Invention Grant
US08207132B2 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
有权
针对桡足类桡足类（海虱）及其抗原序列的重组疫苗
- Patent Title: Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
- Patent Title (中): 针对桡足类桡足类（海虱）及其抗原序列的重组疫苗
-
Application No.: US11572719Application Date: 2005-07-28
-
Publication No.: US08207132B2Publication Date: 2012-06-26
- Inventor: Neil W. Ross , Stewart C. Johnson , Mark D. Fast , Kathryn Vanya Ewart
- Applicant: Neil W. Ross , Stewart C. Johnson , Mark D. Fast , Kathryn Vanya Ewart
- Applicant Address: CA Ottawa, Ontario
- Assignee: National Research Council of Canada
- Current Assignee: National Research Council of Canada
- Current Assignee Address: CA Ottawa, Ontario
- Agency: Borden Ladner Gervais LLP
- Agent David A. Nauman
- International Application: PCT/CA2005/001178 WO 20050728
- International Announcement: WO2006/010265 WO 20060202
- Main IPC: A61K38/08
- IPC: A61K38/08
Abstract:
Molecular targets and vaccines against them in the treatment of sea lice infection of fish are provided, particularly caligid copepods. Vaccines targeted to L. salmonis trypsin are shown to reduce the quantity of sea lice present in challenged salmon from day 14 p.i. onward. Additional and novel molecular targets for vaccines are also provided.
Public/Granted literature
- US20080003233A1 Recombinant Vaccines Against Caligid Copepods (Sea Lice) and Antigen Sequences Thereof Public/Granted day:2008-01-03
Information query
IPC分类:
